Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

4.1%

Beneficial ownership of this reported class.

Shares

1,183,543 shares

Shares beneficially owned as disclosed.

Event date

18 Sep 2025

Date tied to the ownership event or amendment.

Accepted by SEC

22 Sep 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
LENZ
Shares outstanding
28,866,902 shares
Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
22 Sep 2025, 16:20:58 UTC
Event date
18 Sep 2025
Prior SEC filing
20 Aug 2025
Next SEC filing
10 Nov 2025
Source filing
View source filing

Key filing fact

Versant Venture Capital VI, L.P. disclosed 4.1% ownership in LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ) on 18 Sep 2025.

Key facts

  • Versant Venture Capital VI, L.P. filed SCHEDULE 13D/A for LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ).
  • Disclosed ownership: 4.1%.
  • Date of event: 18 Sep 2025.

Change

  • Previous schedule filing date: 20 Aug 2025.
  • Current filing was accepted on 22 Sep 2025, 16:20.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (9)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Versant Venture Capital VI, L.P. 4.1% 1,183,543 1,183,543 0 /s/Max Eisenberg Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the GP of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P. 0001687880
Versant Ventures VI GP, L.P. 4.1% 1,183,543 0 1,183,543 /s/Max Eisenberg Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the General Partner of Versant Ventures VI GP, L.P. 0001777654
Versant Ventures VI GP-GP, LLC 4.1% 1,183,543 0 1,183,543 /s/Max Eisenberg Max Eisenberg/COO 0001777652
Versant Vantage II, L.P. 3% 842,162 842,162 0 /s/Max Eisenberg Max Eisenberg/COO of Versant Vantage II GP-GP, LLC, the GP of Versant Vantage II GP, L.P., the GP of Versant Vantage II, L.P. 0001832235
Versant Vantage II GP, L.P. 3% 842,162 0 842,162 /s/Max Eisenberg Max Eisenberg/COO of Versant Vantage II GP-GP, LLC, the General Partner of Versant Vantage II GP, L.P. 0001839790
Versant Vantage II GP-GP, LLC 3% 842,162 0 842,162 /s/Max Eisenberg Max Eisenberg/COO 0001839789
Versant Venture Capital VII, L.P. 3.2% 926,691 926,691 0 /s/Max Eisenberg Max Eisenberg/COO of Versant Ventures VII GP-GP, LLC, the GP of Versant Ventures VII GP, L.P., the GP of Versant Venture Capital VII, L.P. 0001750266
Versant Ventures VII GP, L.P. 3.2% 926,691 0 926,691 /s/Max Eisenberg Max Eisenberg/COO of Versant Ventures VII GP-GP, LLC, the General Partner of Versant Ventures VII GP, L.P. 0001777655
Versant Ventures VII GP-GP, LLC 3.2% 926,691 0 926,691 /s/Max Eisenberg Max Eisenberg/COO 0001777656
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .